rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2007-9-10
|
pubmed:abstractText |
Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression is analyzed in Swedish melanoma patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0171-5216
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
133
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
859-66
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17492467-Adult,
pubmed-meshheading:17492467-Aged,
pubmed-meshheading:17492467-Aged, 80 and over,
pubmed-meshheading:17492467-Case-Control Studies,
pubmed-meshheading:17492467-DNA-Binding Proteins,
pubmed-meshheading:17492467-Female,
pubmed-meshheading:17492467-Genetic Predisposition to Disease,
pubmed-meshheading:17492467-Genotype,
pubmed-meshheading:17492467-Humans,
pubmed-meshheading:17492467-I-kappa B Proteins,
pubmed-meshheading:17492467-Male,
pubmed-meshheading:17492467-Melanoma,
pubmed-meshheading:17492467-Middle Aged,
pubmed-meshheading:17492467-NF-kappa B p50 Subunit,
pubmed-meshheading:17492467-Phenotype,
pubmed-meshheading:17492467-Polymerase Chain Reaction,
pubmed-meshheading:17492467-Polymorphism, Genetic,
pubmed-meshheading:17492467-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:17492467-Promoter Regions, Genetic,
pubmed-meshheading:17492467-Skin Neoplasms,
pubmed-meshheading:17492467-Sunlight,
pubmed-meshheading:17492467-Sweden
|
pubmed:year |
2007
|
pubmed:articleTitle |
Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients.
|
pubmed:affiliation |
Department of Dermatology, Institute of Biomedicine and Surgery, Linköping University, 581 85, Linköping, Sweden.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|